1645O Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial
| Autor: | J. Capdevila Castillon, M. Plana, B. Castelo, L. Iglesias, J. Hernando, R. Yaya Tur, N. Baste, A. Carmona-Bayonas, S. Ruiz, J. Trigo, I. Lorenzo-Lorenzo, E. Grande, D. Lorente, L. Ugidos, G. Marquina, A. García-Alvarez, M. Taberna, J. Villamayor, J. Molina-Cerrillo, T. Alonso-Gordoa |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S1294-S1295 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.1725 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|